Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 12th, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 12th, 2024 01:33PM | May 12th, 2024 01:33PM | Apellis Pharmaceuticals | ||||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 11th, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 11th, 2024 04:30PM | May 11th, 2024 04:30PM | Apellis Pharmaceuticals | ||||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 10th, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 10th, 2024 01:13PM | May 10th, 2024 01:13PM | Apellis Pharmaceuticals | ||||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 9th, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 24.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 9th, 2024 09:39AM | May 9th, 2024 09:39AM | Apellis Pharmaceuticals | |||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 7th, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 7th, 2024 10:19AM | May 7th, 2024 10:19AM | Apellis Pharmaceuticals | ||||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 4th, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 4th, 2024 06:12PM | May 4th, 2024 06:12PM | Apellis Pharmaceuticals | ||||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 3rd, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 27.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 3rd, 2024 02:36PM | May 3rd, 2024 02:36PM | Apellis Pharmaceuticals | |||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 2nd, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 2nd, 2024 09:26AM | May 2nd, 2024 09:26AM | Apellis Pharmaceuticals | ||||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | May 1st, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | May 1st, 2024 08:58AM | May 1st, 2024 08:58AM | Apellis Pharmaceuticals | ||||||||||
nasdaq:apls | https://www.glassdoor.com?employer_id=1903939 | 1903939 | Apr 30th, 2024 12:00AM | Open | Apellis Pharmaceuticals | Open | Company - Public | Biotech & Pharmaceuticals | Waltham, MA | 2008 | 3.70 | 95% | 59% | 76% | 4.20 | 3.70 | 3.20 | 3.90 | 3.50 | 3.70 | 3.00 | 4.00 | 5.00 | 5.00 | 10.00 | 27.00 | 38.00 | 33.00 | 11.111% | 14.815% | 18.519% | 18.519% | 37.037% | 0.00 | 57.00 | 0.44 | 0.04 | 0.52 | 0.56 | 0.28 | 0.11 | 0.06 | Open | Cedric Francois | Apr 30th, 2024 07:50AM | Apr 30th, 2024 07:50AM | Apellis Pharmaceuticals |